Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Selodenoson in Atrial Fibrillation
NCT00040001Phase 2Completed
- Sponsor
- Aderis Pharmaceuticals
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Selodenoson in Atrial fibrillation (AFib), sponsored by Aderis Pharmaceuticals. Status: completed.
02
Drugs
Selodenoson
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00040001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040001.